Biotechnology

DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease

SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first patients have been ...

2019-08-07 21:00 2032

Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies

YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning diseas...

2019-08-07 10:30 7947

LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI)

CAMBRIDGE, Massachusetts, Aug. 6, 2019 /PRNewswire/ -- LUCA Biologics, a biotechnology company co-founded by Dr.Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist. The company's fir...

2019-08-06 18:00 2010

China Biologic Reports Financial Results for the Second Quarter of 2019

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAA...

2019-08-06 04:30 8271

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...

2019-08-05 08:00 3341

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019

LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...

2019-08-01 04:39 1940

Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution

SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...

2019-07-29 21:42 5392

Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets

REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...

2019-07-29 12:00 5482

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...

2019-07-28 21:47 5538

China Biologic Products to Report Second Quarter 2019 Financial Results

BEIJING, July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 financial resu...

2019-07-27 04:30 10323

LISCure Biosciences Has Completed Seed Funding of USD 5 Million for Bacteria-mediated Immunotherapy R&D Enhancement

SEOUL, South Korea, July 25, 2019 /PRNewswire/ -- LISCure Biosciences, a biotech company that researches and develops bacteria-mediated immunotherapy, has succeeded in attracting5 million USD of seed funding investment. NHN Investment, Shinhan Investment, and KB Securities have participated in th...

2019-07-25 21:00 2191

Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...

2019-07-25 19:00 3232

Mirae Asset Launches China Biotech and Cloud Computing themed ETFs in Hong Kong

HONG KONG, July 25, 2019 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited today is pleased to announce the launch of its 'Mirae Asset Horizons China Biotech ETF' and 'Mirae Asset Horizons China Cloud Computing ETF' inHong Kong, allowing investors to gain exposure to the vast pot...

2019-07-25 09:00 3105

Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock

AUSTIN, Texas, July 24, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced a further strengthening of its balance sheet with an existing investor exercising the balance of its warrant to purchase$4.8 million in aggregate amount of shares of our common stock...

2019-07-25 04:05 9637

Global Cord Blood Corporation Files Its Annual Report on Form 20-F

HONG KONG, July 24, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2019-07-24 04:16 11126

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...

2019-07-23 12:48 3336

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center

SYDNEY, July 22, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) inNew York, NY will investigate the potential use of Kazia's investigational ne...

2019-07-22 09:08 3691

Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US

SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...

2019-07-22 07:00 2976

Kazia calls for greater awareness of the deadliest brain cancer in the US

SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...

2019-07-17 20:00 7756

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., July 17, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps i...

2019-07-17 08:15 3444